Detalhe da pesquisa
1.
Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients.
BMC Cancer
; 19(1): 883, 2019 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31488077
2.
Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia.
Eur J Haematol
; 102(2): 131-142, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30325535
3.
Dexamethasone in hyperleukocytic acute myeloid leukemia.
Haematologica
; 103(6): 988-998, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29519869
4.
Impact of obesity in favorable-risk AML patients receiving intensive chemotherapy.
Am J Hematol
; 91(2): 193-8, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26509505
5.
Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia.
Blood
; 121(14): 2618-26, 2013 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23365464
6.
Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy.
Haematologica
; 99(3): 474-80, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24142998
7.
Intensive chemotherapy, azacitidine, or supportive care in older acute myeloid leukemia patients: an analysis from a regional healthcare network.
Am J Hematol
; 89(12): E244-52, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25195872
8.
Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study.
Leuk Res
; 136: 107437, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215555
9.
Dismal outcome of refractory or relapsing patients with myelodysplasia-related acute myeloid leukemia partially alleviated by intensive chemotherapy.
Cancer Med
; 13(3): e7003, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400682
10.
Vitamin C and D supplementation in acute myeloid leukemia.
Blood Adv
; 7(22): 6886-6897, 2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37671973
11.
Azacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry study.
Leuk Lymphoma
; 63(6): 1398-1406, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35634787
12.
Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia.
Blood Cancer J
; 12(8): 117, 2022 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973983
13.
CD34+CD38-CD123+ Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents.
Cancers (Basel)
; 12(5)2020 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32384744
14.
Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine.
PLoS One
; 15(10): e0238795, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33001991
15.
Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study.
Cancers (Basel)
; 12(8)2020 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32722211
16.
Delivering HDAC over 3 or 5 days as consolidation in AML impacts health care resource consumption but not outcome.
Blood Adv
; 4(16): 3840-3849, 2020 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32790847
17.
Outcome of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia Before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse-Bordeaux DATAML Registry Study.
Cancers (Basel)
; 12(4)2020 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32218221
18.
Outcome of patients aged 60-75 years with newly diagnosed secondary acute myeloid leukemia: A single-institution experience.
Cancer Med
; 8(8): 3846-3854, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31173485
19.
Outcome of AML patients with IDH2 mutations in real world before the era of IDH2 inhibitors.
Leuk Res
; 81: 82-87, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31055247
20.
Improved outcome for AML patients over the years 2000-2014.
Blood Cancer J
; 7(12): 635, 2017 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29184070